paxilline has been researched along with mifepristone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, MH; Liu, YC; So, EC; Wu, SN | 1 |
| Chang, NC; Chen, LC; Chen, TH; Chou, YP; Hsu, SP; Kuo, CT; Lee, TS; Lee, WS; Lin, JJ | 1 |
| Cai, G; Gao, Y; Jia, L; Lu, Y; Mo, F; Shao, J; Sinko, PJ; Xie, F; Yan, C; Yang, X; Yu, S; Yu, T; Zhu, Y | 1 |
3 other study(ies) available for paxilline and mifepristone
| Article | Year |
|---|---|
Glucocorticoids stimulate the activity of large-conductance Ca2+ -activated K+ channels in pituitary GH3 and AtT-20 cells via a non-genomic mechanism.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Dexamethasone; Glucocorticoids; Glyburide; Indoles; Kinetics; Large-Conductance Calcium-Activated Potassium Channels; Mice; Mifepristone; Pituitary Gland; Rats; Scorpion Venoms | 2006 |
Extra-nuclear activation of progesterone receptor in regulating arterial smooth muscle cell migration.
Topics: Animals; Aorta; Arteries; Cell Adhesion; Cell Movement; Cell Nucleus; Cell Proliferation; Gene Expression Regulation; Mifepristone; Myocytes, Smooth Muscle; Oligonucleotides, Antisense; Paxillin; Phosphorylation; Rats; Receptors, Progesterone; src-Family Kinases; Subcellular Fractions | 2011 |
Systems pharmacology of mifepristone (RU486) reveals its 47 hub targets and network: comprehensive analysis and pharmacological focus on FAK-Src-Paxillin complex.
Topics: Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Focal Adhesion Protein-Tyrosine Kinases; Gene Regulatory Networks; Humans; Metabolic Networks and Pathways; Mifepristone; Paxillin; Proto-Oncogene Proteins pp60(c-src) | 2015 |